These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 34647226
1. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis. Sun ZP, Tan ZG, Peng C, Yi WM. J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226 [Abstract] [Full Text] [Related]
2. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma. Zhang L, Jiang G, Lu J, Wang L. Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667 [Abstract] [Full Text] [Related]
3. LncRNA DANCR affected cell growth, EMT and angiogenesis by sponging miR-345-5p through modulating Twist1 in cholangiocarcinoma. Zhu CY, Fan CR, Zhang YL, Sun QX, Yan MJ, Wei W, Liu GF, Liu JJ. Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2321-2334. PubMed ID: 32196584 [Abstract] [Full Text] [Related]
4. LncRNA HOTAIR suppresses cell apoptosis, autophagy and induces cell proliferation in cholangiocarcinoma by modulating the miR-204-5p/HMGB1 axis. Lu M, Qin X, Zhou Y, Li G, Liu Z, Yue H, Geng X. Biomed Pharmacother; 2020 Oct; 130():110566. PubMed ID: 32755793 [Abstract] [Full Text] [Related]
5. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis. Du H, Hou S, Zhang L, Liu C, Yu T, Zhang W. Aging (Albany NY); 2023 May 09; 15(9):3759-3770. PubMed ID: 37166421 [Abstract] [Full Text] [Related]
7. YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2. Li J, Jiang X, Xu Y, Kang P, Huang P, Meng N, Wang H, Zheng W, Wang H, Wang Z, Zhong X, Cui Y. Int J Biol Sci; 2022 May 09; 18(11):4301-4315. PubMed ID: 35864972 [Abstract] [Full Text] [Related]
9. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma. Wu X, Xia M, Chen D, Wu F, Lv Z, Zhan Q, Jiao Y, Wang W, Chen G, An F. Tumour Biol; 2016 Nov 09; 37(11):15019-15029. PubMed ID: 27658773 [Abstract] [Full Text] [Related]
11. Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis. Lu WX. Eur Rev Med Pharmacol Sci; 2019 Sep 09; 23(17):7356-7368. PubMed ID: 31539122 [Abstract] [Full Text] [Related]
12. Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis. Hu Z, Huang L, Wang W, Guan C, Zhao Y, Liu L, Jiang X. Dig Dis Sci; 2022 Feb 09; 67(2):546-558. PubMed ID: 33570683 [Abstract] [Full Text] [Related]
14. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway. Yu J, Zhang B, Zhang H, Qi Y, Wang Y, Wang W, Wang Y, Wang Y. Biochem Biophys Res Commun; 2019 Apr 30; 512(2):150-155. PubMed ID: 30876691 [Abstract] [Full Text] [Related]
20. Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma. Sun Q, Gong X, Wu J, Hu Z, Zhang Q, Gong J, Zhu X. Biomed Res Int; 2021 Apr 30; 2021():8893652. PubMed ID: 34337058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]